Skip to content

DIMREATOX study - Reduction in digestive absorption of toxic substances by combined digestive decontamination in intensive care - randomized single-center study

Status
Not yet recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-518739-12-00
Acronym
APHP231308
Enrollment
200
Registered
2025-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major patients intoxicated by functional toxicant(s), hospitalized in intensive care and intubated.

Brief summary

Percentage change in the plasma concentration of the toxic substance(s) (ingested parent molecules) at 24 hours compared with its/their value(s) at randomisation.

Detailed description

Percentage change in plasma concentration of toxicant(s) (ingested parent molecules) at H48, H72 and H96 compared with the value at randomisation, Area under the concentration curve up to the 96th hour expressed as a percentage of the concentration at randomisation, Number of days alive without mechanical ventilation for 28 days post-randomisation, Number of days alive without resuscitation for 28 days post-randomisation, Number of episodes of vomiting, Number of ventilator-associated pneumonias, Number of episodes of upper abdominal pain and diarrhoea;, Presence of hypersensitivity reactions such as anaphylactic shock, angioedema, urticaria, rash and pruritus.

Interventions

DRUGFORTRANS
DRUGpoudre pour solution buvable en sachet.
DRUGTOXICARB

Sponsors

Assistance Publique Hopitaux De Paris
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Percentage change in the plasma concentration of the toxic substance(s) (ingested parent molecules) at 24 hours compared with its/their value(s) at randomisation.

Secondary

MeasureTime frame
Percentage change in plasma concentration of toxicant(s) (ingested parent molecules) at H48, H72 and H96 compared with the value at randomisation, Area under the concentration curve up to the 96th hour expressed as a percentage of the concentration at randomisation, Number of days alive without mechanical ventilation for 28 days post-randomisation, Number of days alive without resuscitation for 28 days post-randomisation, Number of episodes of vomiting, Number of ventilator-associated pneumonias, Number of episodes of upper abdominal pain and diarrhoea;, Presence of hypersensitivity reactions such as anaphylactic shock, angioedema, urticaria, rash and pruritus.

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026